We are live on ! Find out more
NPSP

NPS PHARMACEUTICALS INC
NPSP

Delisted

NPSP was delisted on the 20th of February, 2015.

Back to rankings

215 hedge funds and large institutions have $3.36B invested in NPS PHARMACEUTICALS INC in 2014 Q2 according to their latest regulatory filings, with 49 funds opening new positions, 78 increasing their positions, 69 reducing their positions, and 44 closing their positions.

New
Increased
Maintained
Reduced
Closed

16% more capital invested

Capital invested by funds: $2.89B → $3.36B (+$465M)

13% more repeat investments, than reductions

Existing positions increased: 78 | Existing positions reduced: 69

11% more first-time investments, than exits

New positions opened: 49 | Existing positions closed: 44

2% more funds holding

Funds holding: 210 → 215 (+5)

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

12% less call options, than puts

Call options by funds: $72.5M | Put options by funds: $82M

Holders
215
Holders Change
+5
Holders Change %
+2.38%
% of All Funds
6.18%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.11%
New
49
Increased
78
Reduced
69
Closed
44
Calls
$72.5M
Puts
$82M
Net Calls
-$9.5M
Net Calls Change
-$5.8M

Top Buyers

Rank Fund Capital Flow
1
Wells Fargo
Wells Fargo
California
+$65.5M
2
Norges Bank
Norges Bank
Norway
+$36.9M
3
Invesco
Invesco
Georgia
+$32.3M
4
VAM
Visium Asset Management
New York
+$29.5M
5
PC
PointState Capital
New York
+$24.6M

Top Sellers

Rank Fund Capital Flow
1
RIM
RS Investment Management
California
-$45.8M
2
CWAM
Columbia Wanger Asset Management
Illinois
-$29.9M
3
Franklin Resources
Franklin Resources
California
-$21.8M
4
CCM
Century Capital Management
Massachusetts
-$17.2M
5
TI
Turner Investments
Pennsylvania
-$14.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
LCG
126
Lisanti Capital Growth
New York
$1.34M +$1.18M +40,695 New
UOC
127
UBS O'Connor
Illinois
$1.32M +$722K +25,000 +167%
GTC
128
Ghost Tree Capital
New York
$1.32M +$1.16M +40,000 New
SGH
129
Sivik Global Healthcare
Connecticut
$1.32M +$1.16M +40,000 New
BG
130
BlackRock Group
United Kingdom
$1.22M -$1.29M -44,739 -55%
Royal Bank of Canada
131
Royal Bank of Canada
Ontario, Canada
$1.22M +$973K +33,695 +1,035%
DILH
132
Dai-ichi Life Holdings
Japan
$1.17M -$20K -694 -2%
EEG
133
E.E. Geduld
$1.16M -$433K -15,000 -30%
Zurich Cantonal Bank
134
Zurich Cantonal Bank
Switzerland
$1.16M – – –
Janney Montgomery Scott
135
Janney Montgomery Scott
Pennsylvania
$1.11M +$108K +3,751 +13%
GCP
136
GSA Capital Partners
United Kingdom
$1.1M -$795K -27,509 -45%
N
137
Nuveen
North Carolina
$1.08M -$79K -2,735 -8%
TRSOTSOK
138
Teachers Retirement System of the State of Kentucky
Kentucky
$1.08M – – –
QI
139
Quotient Investors
New York
$1.02M +$893K +30,900 New
Millennium Management
140
Millennium Management
New York
$1M -$5.63M -194,874 -87%
SM
141
Sabby Management
Florida
$993K +$868K +30,058 New
NAM
142
NorthCoast Asset Management
Connecticut
$985K +$861K +29,799 New
SO
143
STRS Ohio
Ohio
$935K +$396K +13,700 +94%
ARC
144
Absolute Return Capital
Massachusetts
$930K +$813K +28,142 New
Public Employees Retirement Association of Colorado
145
Public Employees Retirement Association of Colorado
Colorado
$924K – – –
PAM
146
Paradigm Asset Management
New York
$876K +$110K +3,800 +17%
SKK
147
Shepherd Kaplan Krochuk
Massachusetts
$856K – – –
JG
148
Jefferies Group
New York
$833K +$728K +25,207 New
MCM
149
Moore Capital Management
New York
$826K +$722K +25,000 New
Mirae Asset Global Investments
150
Mirae Asset Global Investments
South Korea
$779K +$23.5K +814 +4%
4 5
6
7 8

NPSP Hedge Fund Activity: Q2 2014 in Review

215 of the 3,480 institutional investors tracked by Wall St. Rank reported a position in NPS PHARMACEUTICALS INC (NPSP) for Q2 2014, worth a combined $3.36B — up 16% from $2.89B a quarter earlier.

Buyers outnumbered sellers: 49 funds opened new NPSP positions and 44 closed out — a net gain of 5 holders — while 78 added to existing stakes and 69 trimmed.

The largest buyer was Wells Fargo, adding an estimated $65.5M. The largest seller was RS Investment Management, exiting entirely with an estimated $45.8M sold.

  • 215 institutional investors held NPS PHARMACEUTICALS INC (NPSP) as of Q2 2014, up from 210 in Q1 2014.
  • Funds reported $3.36B of NPS PHARMACEUTICALS INC stock for Q2 2014, up 16% quarter-over-quarter.
  • 49 funds opened new NPS PHARMACEUTICALS INC positions in Q2 2014 and 44 closed out, a net change of +5 holders.
  • The largest NPS PHARMACEUTICALS INC buyer in Q2 2014 was Wells Fargo, an estimated $65.5M added.
  • The largest NPS PHARMACEUTICALS INC seller in Q2 2014 was RS Investment Management, an estimated $45.8M sold.

Based on aggregated 13F filings for Q2 2014.